You have 9 free searches left this month | to do more

idarubicin

Idarubicin is a drug used to treat Leukemia, Acute Myeloid Leukemia, and Myelodysplastic Syndromes. Idarubicin is being actively studied in 37 studies and prior, has been studied in 84.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterM D Anderson Cancer CenterAmir Fathi
European Organisation for Research and Treatment of Cancer - EORTCLeiden University Medical CenterProf. Dr. Richard Schlenk
National Cancer Institute (NCI)Roswell Park Cancer InstituteQifa Liu
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Terminated
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Illinois at Chicago
2021-07-01
Jul 1, 2021
G
Completed
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Frankfurt am Main, Hessen, Germany
  • +2 more
2021-08-01
Aug 1, 2021
H
Completed
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Idarubicin
  • +2 more
  • Tampa, Florida
  • +1 more
2020-12-01
Dec 1, 2020
C
Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
2022-03-28
Mar 28, 2022
M
U
Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Tucson, Arizona
  • +2 more
2021-10-14
Oct 14, 2021
C
Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-02-28
Feb 28, 2022
M
Completed
  • Untreated Adult Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2020-11-28
Nov 28, 2020
T
Recruiting
  • Acute Promyelocytic Leukemia
  • Arsenic trioxide
  • +6 more
  • Multiple Locations, France
  • +7 more
2022-03-22
Mar 22, 2022
R
Withdrawn
  • Leukemia
  • recombinant interferon alfa
  • +7 more
  • Chicago, Illinois
  • +3 more
2021-10-06
Oct 6, 2021
P
Recruiting
  • APL
  • Valencia, Spain
    Hospital La Fe
2021-03-22
Mar 22, 2021
M
Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +2 more
2022-01-21
Jan 21, 2022
M
Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-09-09
Sep 9, 2021
N
Completed
  • Acute Myeloid Leukemia
  • Idarubicin
  • +4 more
  • Augusta, Georgia
  • +1 more
2020-06-03
Jun 3, 2020
M
Completed
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
2020-04-23
Apr 23, 2020
D
Completed
  • Acute Myeloid Leukemia
  • Tokyo, Japan
    (unnamed)
2021-07-26
Jul 26, 2021
L
Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
2021-10-07
Oct 7, 2021
M
Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2019-11-14
Nov 14, 2019
F
Recruiting
  • AML in Remission
  • Idarubicin
  • ID cytarabine
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
2020-01-01
Jan 1, 2020
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
2022-03-09
Mar 9, 2022